Legal Representation
Attorney
Brooks R. Bruneau
USPTO Deadlines
Next Deadline
873 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-29)
Due Date
March 29, 2028
Grace Period Ends
September 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 19, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Sep 12, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 23, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Aug 23, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jun 29, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| May 8, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Mar 29, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 11, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 11, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 10, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Dec 22, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 22, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Dec 22, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 9, 2021 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 9, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 8, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 6, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 6, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 6, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 11, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 25, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 25, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Aug 7, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Aug 6, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 3, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 12, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 7, 2021 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jun 3, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use
Class 042
Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services
Classification
International Classes
005
042